USA Today reports:
... Celebrex doubled the risk of serious cardiovascular problems, including heart attacks, strokes, heart failure and death, according to a separate analysis in the journal Circulation released Wednesday. That makes Celebrex too risky to be used for polyp prevention, according to an editorial in the New England Journal by Bruce Psaty of the University of Washington and John Potter of the Fred Hutchinson Cancer Research Center in Seattle.
No comments:
Post a Comment